Hydromorphone Hydrochloride Ethypharm (Hydromorphone Hydrochloride)

Hydromorphone Hydrochloride is an opioid analgesic used in the management of pain conditions that require strong opioid therapy.

• Post‑operative pain: provides rapid and potent analgesia after surgical procedures.
• Cancer‑related pain: helps control moderate to severe pain associated with malignant disease.
• Acute severe pain: offers effective relief for sudden, intense pain episodes such as trauma or renal colic.

• Hydromorphone Hydrochloride acts as a full agonist at the mu‑opioid receptors in the central nervous system. Binding to these G‑protein‑coupled receptors inhibits adenylate cyclase activity, reduces calcium influx, and increases potassium efflux, leading to decreased neuronal excitability and diminished transmission of nociceptive signals, thereby producing analgesia.

Hydromorphone Hydrochloride may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects

• Nausea: mild to moderate upset stomach and vomiting.
• Constipation: reduced bowel motility leading to hard stools.
• Drowsiness: increased sleepiness or fatigue.
• Dry mouth: reduced salivary flow causing a parched feeling.
• Sweating: excessive perspiration unrelated to temperature.
• Itching: mild pruritus, often at the injection site.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be fatal.
• Hypotension: significant drop in blood pressure causing dizziness.
• Severe allergic reaction: rash, swelling, or anaphylaxis.
• Seizures: rare occurrence of convulsive episodes.
• Dependence or withdrawal: potential for physical dependence with prolonged use.

Hydromorphone Hydrochloride requires careful clinical assessment before use.

• Patient assessment: evaluate pain severity, opioid tolerance, and comorbidities.
• Respiratory monitoring: observe for signs of respiratory depression, especially after dose initiation or escalation.
• Concomitant CNS depressants: avoid or limit use with benzodiazepines, barbiturates, or alcohol.
• Renal or hepatic impairment: adjust dosing and monitor organ function closely.
• Pregnancy and lactation: use only if benefits outweigh potential risks; consult obstetric guidance.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Hydromorphone Hydrochloride can interact with several drug classes, altering its safety or efficacy.

Major Interactions (Avoid)

• Other opioids: additive respiratory depression and sedation.
• CNS depressants (e.g., benzodiazepines, barbiturates): heightened risk of profound sedation and respiratory compromise.
• MAO inhibitors: possible severe hypotension or serotonin syndrome.

Moderate Interactions (Monitor Closely):\n- CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase plasma levels of hydromorphone.

• CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce analgesic effect.
• Anticholinergic agents: may exacerbate constipation.